Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress.

Aridgides DS, Mellinger DL, Armstrong DA, Hazlett HF, Dessaint JA, Hampton TH, Atkins GT, Carroll JL, Ashare A.

Sci Rep. 2019 Jul 3;9(1):9624. doi: 10.1038/s41598-019-46045-7.

2.

Dissociation of systemic and mucosal autoimmunity in cystic fibrosis.

Theprungsirikul J, Skopelja-Gardner S, Meagher RE, Clancy JP, Zemanick ET, Ashare A, Rigby WFC.

J Cyst Fibros. 2019 Jun 28. pii: S1569-1993(19)30807-0. doi: 10.1016/j.jcf.2019.06.006. [Epub ahead of print]

PMID:
31262645
3.

Genome-wide DNA methylation profiling shows a distinct epigenetic signature associated with lung macrophages in cystic fibrosis.

Chen Y, Armstrong DA, Salas LA, Hazlett HF, Nymon AB, Dessaint JA, Aridgides DS, Mellinger DL, Liu X, Christensen BC, Ashare A.

Clin Epigenetics. 2018 Dec 10;10(1):152. doi: 10.1186/s13148-018-0580-2.

4.

Evolution of drug resistance in an antifungal-naive chronic Candida lusitaniae infection.

Demers EG, Biermann AR, Masonjones S, Crocker AW, Ashare A, Stajich JE, Hogan DA.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12040-12045. doi: 10.1073/pnas.1807698115. Epub 2018 Nov 2.

5.

Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases.

Facciponte DN, Bough MW, Seidler D, Carroll JL, Ashare A, Andrew AS, Tsongalis GJ, Vaickus LJ, Henegan PL, Butt TH, Stommel EW.

Sci Total Environ. 2018 Dec 15;645:1003-1013. doi: 10.1016/j.scitotenv.2018.07.226. Epub 2018 Jul 20.

PMID:
30248825
6.

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA.

Grahl N, Dolben EL, Filkins LM, Crocker AW, Willger SD, Morrison HG, Sogin ML, Ashare A, Gifford AH, Jacobs NJ, Schwartzman JD, Hogan DA.

mSphere. 2018 Aug 8;3(4). pii: e00292-18. doi: 10.1128/mSphere.00292-18.

7.

Pre-Analytical Handling Conditions and Small RNA Recovery from Urine for miRNA Profiling.

Armstrong DA, Dessaint JA, Ringelberg CS, Hazlett HF, Howard L, Abdalla MAK, Barnaby RL, Stanton BA, Cervinski MA, Ashare A.

J Mol Diagn. 2018 Sep;20(5):565-571. doi: 10.1016/j.jmoldx.2018.04.003. Epub 2018 Jun 22.

PMID:
29936254
8.

VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.

Ceeraz S, Eszterhas SK, Sergent PA, Armstrong DA, Ashare A, Broughton T, Wang L, Pechenick D, Burns CM, Noelle RJ, Vincenti MP, Fava RA.

Arthritis Res Ther. 2017 Dec 8;19(1):270. doi: 10.1186/s13075-017-1474-y.

9.

Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa.

Barnaby R, Koeppen K, Nymon A, Hampton TH, Berwin B, Ashare A, Stanton BA.

Am J Physiol Lung Cell Mol Physiol. 2018 Mar 1;314(3):L432-L438. doi: 10.1152/ajplung.00461.2017. Epub 2017 Nov 16.

10.

Pulmonary microRNA profiling: implications in upper lobe predominant lung disease.

Armstrong DA, Nymon AB, Ringelberg CS, Lesseur C, Hazlett HF, Howard L, Marsit CJ, Ashare A.

Clin Epigenetics. 2017 May 30;9:56. doi: 10.1186/s13148-017-0355-1. eCollection 2017.

11.

The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.

Skopelja S, Hamilton BJ, Jones JD, Yang ML, Mamula M, Ashare A, Gifford AH, Rigby WF.

JCI Insight. 2016 Oct 20;1(17):e88912. doi: 10.1172/jci.insight.88912.

12.

Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients.

Seidler D, Griffin M, Nymon A, Koeppen K, Ashare A.

PLoS One. 2016 Oct 6;11(10):e0164232. doi: 10.1371/journal.pone.0164232. eCollection 2016.

13.

Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.

Gifford AH, Willger SD, Dolben EL, Moulton LA, Dorman DB, Bean H, Hill JE, Hampton TH, Ashare A, Hogan DA.

Infect Immun. 2016 Sep 19;84(10):2995-3006. doi: 10.1128/IAI.00437-16. Print 2016 Oct.

14.

Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.

Hogan DA, Willger SD, Dolben EL, Hampton TH, Stanton BA, Morrison HG, Sogin ML, Czum J, Ashare A.

PLoS One. 2016 Mar 4;11(3):e0149998. doi: 10.1371/journal.pone.0149998. eCollection 2016.

15.

Ice Hockey Summit II: zero tolerance for head hits and fighting.

Smith AM, Stuart MJ, Dodick DW, Roberts WO, Alford PW, Ashare AB, Aubrey M, Benson BW, Burke CJ, Dick R, Eickhoff C, Emery CA, Flashman LA, Gaz D, Giza CC, Greenwald RM, Herring S, Hoshizaki TB, Hudziak JJ, Huston J 3rd, Krause D, LaVoi N, Leaf M, Leddy JJ, MacPherson A, McKee AC, Mihalik JP, Moessner AM, Montelpare WJ, Putukian M, Schneider KJ, Szalkowski R, Tabrum M, Whitehead J, Wiese-Bjornstal DM.

Clin J Sport Med. 2015 Mar;25(2):78-87. doi: 10.1097/JSM.0000000000000195. Erratum in: Clin J Sport Med. 2015 Jul;25(4):379.

PMID:
25866860
16.

Ice hockey summit II: zero tolerance for head hits and fighting.

Smith AM, Stuart MJ, Dodick DW, Roberts WO, Alford PW, Ashare AB, Aubrey M, Benson BW, Burke CJ, Dick R, Eickhoff C, Emery CA, Flashman LA, Gaz DV, Giza CC, Greenwald RM, Herring SA, Hoshizaki TB, Hudziak JJ, Huston J 3rd, Krause D, LaVoi N, Leaf M, Leddy JJ, MacPherson A, McKee AC, Mihalik JP, Moessner AM, Montelpare WJ, Putukian M, Schneider KJ, Szalkowski R, Tabrum M, Whitehead JR, Wiese-Bjornstal DM.

PM R. 2015 Mar;7(3):283-95. doi: 10.1016/j.pmrj.2015.02.002. Erratum in: PM R. 2015 May;7(5):552.

PMID:
25797614
17.

Ice Hockey Summit II: zero tolerance for head hits and fighting.

Smith AM, Stuart MJ, Dodick DW, Roberts WO, Alford PW, Ashare AB, Aubrey M, Benson BW, Burke CJ, Dick R, Eickhoff C, Emery CA, Flashman LA, Gaz DV, Giza CC, Greenwald RM, Herring SA, Hoshizaki TB, Hudziak JJ, Huston J 3rd, Krause D, LaVoi N, Leaf M, Leddy JJ, MacPherson A, McKee AC, Mihalik JP, Moessner AM, Montelpare WJ, Putukian M, Schneider KJ, Szalkowski R, Tabrum M, Whitehead JR, Wiese-Bjornstal DM.

Curr Sports Med Rep. 2015 Mar-Apr;14(2):135-44. doi: 10.1249/JSR.0000000000000132.

PMID:
25757010
18.

Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis.

Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, Morrison HG, Filkins LM, O'Toole GA, Moulton LA, Ashare A, Sogin ML, Hogan DA.

Microbiome. 2014 Nov 3;2:40. doi: 10.1186/2049-2618-2-40. eCollection 2014.

19.

Serum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.

Gifford AH, Nymon AB, Ashare A.

Pediatr Pulmonol. 2014 Apr;49(4):335-41. doi: 10.1002/ppul.22822. Epub 2013 Jun 18.

20.

Low levels of insulin-like growth factor-1 contribute to alveolar macrophage dysfunction in cystic fibrosis.

Bessich JL, Nymon AB, Moulton LA, Dorman D, Ashare A.

J Immunol. 2013 Jul 1;191(1):378-85. doi: 10.4049/jimmunol.1300221. Epub 2013 May 22.

21.

Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.

Ashare A, Stanford C, Hancock P, Stark D, Lilli K, Birrer E, Nymon A, Doerschug KC, Hunninghake GW.

Clin Transl Sci. 2009 Jun;2(3):199-205. doi: 10.1111/j.1752-8062.2009.00122.x.

22.

Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis.

Hunninghake GW, Doerschug KC, Nymon AB, Schmidt GA, Meyerholz DK, Ashare A.

Am J Respir Crit Care Med. 2010 Aug 15;182(4):517-25. doi: 10.1164/rccm.200911-1757OC. Epub 2010 Apr 22.

23.

Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis.

Doerschug KC, Delsing AS, Schmidt GA, Ashare A.

Crit Care. 2010;14(1):R24. doi: 10.1186/cc8887. Epub 2010 Feb 22.

24.

Returning to play after concussion.

Ashare AB.

Acta Paediatr. 2009 May;98(5):774-6. doi: 10.1111/j.1651-2227.2009.01300.x. No abstract available.

PMID:
19389120
25.

Patterns and density of early tracheal colonization in intensive care unit patients.

Durairaj L, Mohamad Z, Launspach JL, Ashare A, Choi JY, Rajagopal S, Doern GV, Zabner J.

J Crit Care. 2009 Mar;24(1):114-21. doi: 10.1016/j.jcrc.2008.10.009.

26.

Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity.

Monick MM, Powers LS, Barrett CW, Hinde S, Ashare A, Groskreutz DJ, Nyunoya T, Coleman M, Spitz DR, Hunninghake GW.

J Immunol. 2008 Jun 1;180(11):7485-96.

27.

Insulin-like growth factor-1 improves survival in sepsis via enhanced hepatic bacterial clearance.

Ashare A, Nymon AB, Doerschug KC, Morrison JM, Monick MM, Hunninghake GW.

Am J Respir Crit Care Med. 2008 Jul 15;178(2):149-57. doi: 10.1164/rccm.200709-1400OC. Epub 2008 Apr 24.

28.

Pseudomonas aeruginosa delays Kupffer cell death via stabilization of the X-chromosome-linked inhibitor of apoptosis protein.

Ashare A, Monick MM, Nymon AB, Morrison JM, Noble M, Powers LS, Yarovinsky TO, Yahr TL, Hunninghake GW.

J Immunol. 2007 Jul 1;179(1):505-13.

30.

Severe bacteremia results in a loss of hepatic bacterial clearance.

Ashare A, Monick MM, Powers LS, Yarovinsky T, Hunninghake GW.

Am J Respir Crit Care Med. 2006 Mar 15;173(6):644-52. Epub 2006 Jan 6.

31.

Anti-inflammatory response is associated with mortality and severity of infection in sepsis.

Ashare A, Powers LS, Butler NS, Doerschug KC, Monick MM, Hunninghake GW.

Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L633-40. Epub 2004 Dec 3.

32.

Sudden death due to neck blows among amateur hockey players.

Maron BJ, Poliac LC, Ashare AB, Hall WA.

JAMA. 2003 Aug 6;290(5):599-601. No abstract available.

PMID:
12902362
33.

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW.

J Clin Invest. 2003 Mar;111(5):717-25.

34.

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM.

Circulation. 1998 Dec 22-29;98(25):2800-4.

PMID:
9860779
35.

Artificial neural networks: better than the real thing?

Ashare AB, Chakraborty DP.

J Nucl Med. 1994 Dec;35(12):2048-9. No abstract available.

36.

Radiocolloid liver scintigraphy. A choice and an echo.

Ashare AB.

Radiol Clin North Am. 1980 Aug;18(2):315-9. Review.

PMID:
7010413
37.

Thyroid scintigraphy: pinhole images versus rectilinear scans.

Sostre S, Ashare AB, Quinones JD, Schieve JB, Zimmerman JM.

Radiology. 1978 Dec;129(3):759-62.

PMID:
725054
38.

Field flood uniformity correction: benefits or pitfalls?

Padikal TN, Ashare AB, Kereiakes JG.

J Nucl Med. 1976 Jul;17(7):653-6.

39.

Cesium-129 myocardial scintigraphy to quantify myocardial infarction in dogs.

Romhilt DW, Ashare AB, Adolph RJ, Levenson NI, Wee WG, Sodd VJ, August LS.

J Nucl Med. 1976 Apr;17(4):247-52.

40.

Quantitative assessment of field uniformity for gamma cameras.

Cohen G, Kereiakes JG, Padikal TN, Ashare AB, Saenger EL.

Radiology. 1976 Jan;118(1):197-200.

PMID:
1244658
41.

The Gamut approach to scintigram interpretation--diagnostic aid and teaching method.

Holder LE, Ashare AB, Tomsick T, Colley DP, Fernandez M, Catz Z, Saenger EL.

J Nucl Med. 1975 Dec;16(12):1121-4.

42.

Hepatic artery traumatic aneurysm.

Smith W, Ashare AB, Saenger EL.

J Nucl Med. 1975 Nov;16(11):1027-28.

43.

Interpretation of radionuclide liver images: do training and experience make a difference?

Nishiyama H, Lewis JT, Ashare AB, Saenger EL.

J Nucl Med. 1975 Jan;16(1):11-6.

44.

G suit filling pressures determined by seat back angle.

Frazier JW, Whitney RU, Ashare AB, Rogers DB, Skowronski VD.

Aerosp Med. 1974 Jul;45(7):755-7. No abstract available.

PMID:
4837192
45.

A comparison of 123I and 131I for thyroid imaging using various collimators.

Nishiyama H, Ashare AB, Shafie A, Saenger EL, Sodd VJ.

Int J Nucl Med Biol. 1974 Jun;1(4):201-4. No abstract available.

PMID:
4435996
46.

Letter to the editor.

Aronow S, Ashare AB.

J Nucl Med. 1967 Aug;8(8):623-4. No abstract available.

Supplemental Content

Loading ...
Support Center